Á lódáil...
Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer
Perioperative adjuvant treatment has become an increasingly important aspect of the management of patients with non‐small cell lung cancer (NSCLC). In particular, the success of immune checkpoint inhibitors, such as antibodies against PD‐1 and PD‐L1, in patients with lung cancer has increased our ex...
Na minha lista:
| Foilsithe in: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley & Sons Australia, Ltd
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088961/ https://ncbi.nlm.nih.gov/pubmed/33787090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13942 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|